Literature DB >> 729834

Regression of a prolactin-secreting pituitary tumor during long-term treatment with bromocriptine.

S J Nillius, T Bergh, P O Lundberg, J Stahle, L Wide.   

Abstract

A nulliparous woman with 12 years of amenorrhea, galactorrhea, and hyperprolactinemia and radiologic evidence of a pituitary macroadenoma was treated with large doses of bromocriptine. During treatment the greatly increased prolactin levels normalized and ovulatory menstrual cycles were regained after 48 weeks of treatment. A transsphenoidal surgical exploration of the pituitary fossa was performed after 27 months of treatment. The findings at surgery suggested that regression of the pituitary adenoma had occurred during the prolonged treatment with bromocriptine. After discontinuation of the therapy, the patient continued to ovulate and subsequently conceived.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 729834     DOI: 10.1016/s0015-0282(16)43702-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

1.  Effect of dopamine agonist medication on prolactin producing pituitary adenomas. A morphological study including immunocytochemistry, electron microscopy and in situ hybridization.

Authors:  K Kovacs; L Stefaneanu; E Horvath; R V Lloyd; I Lancranjan; M Buchfelder; R Fahlbusch
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 2.  Medical treatment of pituitary adenomas: effects on tumor growth.

Authors:  A Liuzzi; P G Chiodini; D Dallabonzana; G Oppizzi; G G Verde
Journal:  J Endocrinol Invest       Date:  1985-06       Impact factor: 4.256

Review 3.  Management of endocrine disorders in pregnancy. Part II. Pituitary, ovarian and adrenal disease.

Authors:  Z M van der Spuy; H S Jacobs
Journal:  Postgrad Med J       Date:  1984-05       Impact factor: 2.401

4.  Partial remission of hyperprolactinemic amenorrhea after bromocriptine-induced pregnancy.

Authors:  C Campagnoli; L Belforte; F Massara; C Peris; G M Molinatti
Journal:  J Endocrinol Invest       Date:  1981 Jan-Mar       Impact factor: 4.256

5.  CT follow-up of microprolactinomas during bromocriptine-induced pregnancy.

Authors:  J L Dietemann; C Portha; F Cattin; E Mollet; J F Bonneville
Journal:  Neuroradiology       Date:  1983       Impact factor: 2.804

6.  Effects of bromocriptine on pituitary tumour size.

Authors:  A M McGregor; M F Scanlon; R Hall; K Hall
Journal:  Br Med J       Date:  1979-09-22

Review 7.  Pituitary tumors--current concepts of diagnosis and therapy.

Authors:  D M Cook
Journal:  West J Med       Date:  1980-09

Review 8.  The endocrine profile of bromocriptine: its application in endocrine diseases.

Authors:  I Lancranjan
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.